Spontaneous tolerance to terbinafine-induced lichenoid drug eruption [2]

Dermatology

Volumn 208, Issue 1, 2004, Pages 81-82

  Teraki, Yuichi ^a   Shiohara, Tetsuo ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

Lichenoid drug eruption; Lymphocyte transformation test; Terbinafine

Indexed keywords

ANTIFUNGAL AGENT; TERBINAFINE; TICLOPIDINE;

AGED; ANAMNESIS; BRAIN INFARCTION; CASE REPORT; CLINICAL FEATURE; DRUG ERUPTION; DRUG WITHDRAWAL; ERYTHEMA; ERYTHEMA MULTIFORME; HUMAN; HUMAN TISSUE; HYPERSENSITIVITY; LABORATORY TEST; LEG; LETTER; LICHENOID ERUPTION; LYMPHOCYTE TRANSFORMATION TEST; MALE; ONYCHOMYCOSIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PUSTULOSIS; RASH; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; SKIN MANIFESTATION; TOXIC EPIDERMAL NECROLYSIS; URINALYSIS; URTICARIA;

AGED; ANTIFUNGAL AGENTS; DRUG TOLERANCE; HUMANS; LICHENOID ERUPTIONS; MALE; NAPHTHALENES; ONYCHOMYCOSIS;

EID: 0942268179     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075054     Document Type: Letter

References (17)

1. Halevy S, Shai A: Lichenoid drug eruptions. J Am Acad Dermatol 1993;29:249-255.
2. Roujeau JC, Albengres E, Moritz S, Piacentino A, Cuny M, Revuz J, Touraine R: Lymphocyte transformation test in drug-induced toxic epidermal necrolysis. Int Arch Allergy Appl Immunol 1985;78:22-24.
3. Nyfeler B, Pichler WJ: The lymphocyte transformation test for the diagnosis of drug allergy: Sensitivity and specificity. Clin Exp Allergy 1997;27:175-181.
4. Hertl M, Merk HF: Lymphocyte activation in cutaneous drug reactions. J Invest Dermatol 1995;105:95S-98S.
5. Muto M, Kawachi S, Fukuzawa M, Saida T: Evaluation of diagnostic significance of the drug-induced lymphocyte stimulation test in drug eruptions. Jpn J Dermatol 2000;110:1543-1548.
6. Gupta AK, Shear NH: Terbinafine: An update. J Am Acad Dermatol 1997;37:979-988.
7. Gupta AK, Lynde CW, Lauzon GJ, Mehlmauer MA, Braddock SW, Miller CA, Del Rosso JQ, Shear NH: Cutaneous adverse effects associated with terbinafine therapy: 10 case reports and a review of the literature. Br J Dermatol 1998;138:529-532.
8. McGregor JM, Rustin MH: Terbinafine and erythema multiforme. Br J Dermatol 1994;131:587-588.
9. Carstens J, Wendelboe P, Sogaard H, Thestrup-Pedersen K: Toxic epidermal necrolysis and erythema multiforme following therapy with terbinafine. Acta Derm Venereol 1994;74:391-392.
10. Munn SE, Russell Jones R: Terbinafine and fixed drug eruption. Br J Dermatol 1995;133:815-816.
11. Hall AP, Tate B: Acute generalized exanthematous pustulosis associated with oral terbinafine. Australas J Dermatol 2000;41:42-45.
12. Gupta AK, Kopstein JB, Shear NH: Hypersensitivity reaction to terbinafine. J Am Acad Dermatol 1997;36:1018-1019.
13. Gupta AK, Sibbald RG, Knowles SR, Lynde CW, Shear NH: Terbinafine therapy may be associated with the development of psoriasis de novo or its exacerbation: Four case reports and a review of drug-induced psoriasis. J Am Acad Dermatol 1997;36:858-862.
14. Bonsmann G, Schiller M, Luger TA, Stander S: Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2001;44:925-931.
15. Anderson TE: Lichen planus following quinidine therapy. Br J Dermatol 1967;79:500.
16. Seehafer JR, Rogers RS 3rd, Fleming CR, Dickson ER: Lichen planus-like lesions caused by penicillamine in primary biliary cirrhosis. Arch Dermatol 1981;117:140-142.
17. Shiohara T, Moriya N, Nagashima M: The lichenoid tissue reaction: A new concept of pathogenesis. Int J Dermatol 1988;27:365-374.